EULAR Recommendations for ANCA Vasculitis

ERN-RITA & EUVAS webinar: Updated EULAR recommendations on ANCA Associated VasculitisПодробнее

JC_rhmtlgy 13: "Aktuelle Therapie der ANCA-assoziierten Vaskulitiden: neue EULAR-Recommendations“Подробнее

Vasculitis Abstracts from EULAR 2022Подробнее

CanVasc Consensus Recommendations for the Management of ANCA-associated Vasculitis: Arielle MendelПодробнее

2022 ASAS/EULAR Recommendations on the Management of Axial SpondyloarthritisПодробнее

ANCA-associated Vasculitis: Update Therapy 2023 - Prof. Dr. Alexandre Karras (Paris, France)Подробнее

New 2022 ASAS/EULAR Recommendations on the Management of Axial SpondyloarthritisПодробнее

Report from EULAR Advances in Research and TreatmentsПодробнее

EULAR Recommendations for Rheumatoid ArthritisПодробнее

Enticing New Options in ANCA-Associated VasculitisПодробнее

Opportunities to Further Care in ANCA-Associated Vasculitis: GPA and MPAПодробнее

Lower Dose Rituximab in ANCA VasculitisПодробнее

KDIGO 2024 ANCA Vasculitis Guideline: Reading Between the LinesПодробнее

Dr. Len Calabrese - EULAR 2018 Vasculitis Update on C5a Receptor Inhibitor in ANCA+ VasculitisПодробнее

EULAR 2022 - Day 2 Faculty Recap PanelПодробнее

KDIGO 2024 Guideline on ANCA-Associated Vasculitis: Update on Current Management and TreatmentПодробнее

Another Take on the 2022 EULAR RA Treatment GuidelinesПодробнее

EULAR Recommendations Podcast 2023 with Professor Peter Nash & Dr. Andreas KerschbaumerПодробнее

Highlights From EULAR 2022Подробнее